[HTML][HTML] Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited

KH Plate, A Scholz, DJ Dumont - Acta neuropathologica, 2012 - Springer
The cellular and molecular mechanisms of tumor angiogenesis and its prospects for anti-
angiogenic cancer therapy are major issues in almost all current concepts of both cancer …

[HTML][HTML] Anti-angiogenic therapies in the management of glioblastoma

JD Schulte, MK Aghi, JW Taylor - Chinese clinical oncology, 2021 - ncbi.nlm.nih.gov
Angiogenesis is a central feature of glioblastoma (GBM), with contribution from several
mechanisms and signaling pathways to produce an irregular, poorly constructed, and poorly …

Vascular microenvironment in gliomas

P Vajkoczy, MD Menger - Journal of neuro-oncology, 2000 - Springer
Structural and functional abnormalities of the vascular microenvironment determine
pathophysiological characteristics of gliomas, such as loss of blood–brain barrier function …

Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation

S Takano - Brain tumor pathology, 2012 - Springer
Glioblastomas are highly vascular tumors. Recent preclinical and clinical investigations
have revealed that agents targeting angiogenesis may have efficacy against this type of …

Vascular microenvironment in gliomas

P Vajkoczy, MD Menger - Angiogenesis in Brain Tumors, 2004 - Springer
Structural and functional abnormalities of the vascular microenvironment determine
pathophysiological characteristics of gliomas, such as loss of blood-brain barrier function …

[HTML][HTML] Exploring the past, present, and future of anti-angiogenic therapy in glioblastoma

AB Zhang, K Mozaffari, B Aguirre, V Li, R Kubba… - Cancers, 2023 - mdpi.com
Simple Summary Glioblastoma is the most common malignant primary brain tumor. Despite
technological advancements and modern therapeutic agents used for treatment, the …

Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma

R Rahman, S Smith, C Rahman… - Journal of Oncology, 2010 - Wiley Online Library
Despite advances in surgery, radiation therapy, and chemotherapeutics, patients with
malignant glioma have a dismal prognosis. The formations of aberrant tumour vasculature …

[HTML][HTML] Interactions between anti-angiogenic therapy and immunotherapy in glioblastoma

S Jain, EJ Chalif, MK Aghi - Frontiers in Oncology, 2022 - frontiersin.org
Glioblastoma is the most aggressive brain tumor with a median survival of less than 15
months. The complex interactions between the tumor and the cells of the tumor …

[HTML][HTML] Mechanisms of glioma-associated neovascularization

ME Hardee, D Zagzag - The American journal of pathology, 2012 - Elsevier
Glioblastomas (GBMs), the most common primary brain tumor in adults, are characterized by
resistance to chemotherapy and radiotherapy. One of the defining characteristics of GBM is …

Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme

Y Soda, C Myskiw, A Rommel, IM Verma - Journal of molecular medicine, 2013 - Springer
Glioblastoma multiforme (GBM) is the most malignant brain tumor and highly resistant to
intensive combination therapies. GBM is one of the most vascularized tumors and vascular …